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SUMMARY
In a study to estimate the frequency of Cryptosporidium infections in Switzerland, stool samples
from patients found to be positive for Cryptosporidium spp. by modiﬁed Ziehl–Neelson staining
and ﬂuorescence microscopy were used for genotyping experiments. With 9 of 12 samples, DNA
extraction and subsequent genotyping was successful. All Cryptosporidium-isolates belonged to
the bovine genotype. In one stool sample, two strains of Cryptosporidium were demonstrated,
suggesting a mixed infection. In comparison with reference strains from calves, one of the isolates
showed a full sequence identity and the other a similarity of 97.5%. The fact that only bovine
genotypes were detected suggests, that cryptosporidiosis must primarily be considered as a
zoonotic disease in Switzerland. This is in contrast to other countries, where the human genotype
of C. parvum was shown to dominate the epidemiological situation. The results of our study are
supported by the previous ﬁnding, that two of the analysed strains originated from patients who
used to consume raw milk or raw cream, a known risk factor for cryptosporidiosis.
INTRODUCTION
Cryptosporidium is a protozoan parasite which infects
mainly the apical region of epithelial cells lining the
gastrointestinal tract or associated organs such as the
biliary tract of vertebrates and sometimes the respir-
atory tract [1]. Prior to the 1980’s, infections with
species of the genus Cryptosporidium were considered
to be rare in animals. In humans, Cryptosporidium
was thought to be an opportunistic pathogen in im-
munocompromised individuals. Nowadays however,
it is apparent that the species Cryptosporidium parvum
is responsible for zoonotic and anthroponotic infec-
tions in both urban and rural settings worldwide. The
parasite causes self-limiting diarrhoea in immuno-
competent humans, and severe, persistent or chronic
life-threatening diarrhoea in immunocompromised
patients, particularly in those suﬀering from the
acquired immunodeﬁciency syndrome, AIDS [1–3].
Cryptosporidial infections are now considered as one
of the most common non-viral and non-bacterial
causes of diarrhoea in humans and livestock [4].
Symptoms are relatively non-speciﬁc, namely nausea,
acute onset of profuse and watery diarrhoea, lack of
appetite, vomiting, weight loss, abdominal pain and
ﬂu-like symptoms [1, 5]. Infections are transmitted
faecal-orally (ingestion or inhalation), either directly
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indirectly through contaminated vectors like water or
food [5, 6].
Various Cryptosporidium species have now been
recorded in over 170 diﬀerent host animals originat-
ing from over 50 countries [5]. Taxonomically, the 11
following species are known: C. parvum, C. wrairi,
C. meleagridis, C. saurophilum, C. felis, C. canis,
C. baileyi, C. muris, C. andersoni, C. serpentis, C. na-
sorum [3, 7, 8]. Cryptosporidium parvum has been
considered to be the only species that infects im-
munocompetent humans [5, 9]. However, this classi-
ﬁcation, based mainly on morphology, biology and
genetic information, is still changing and more data
are needed before the taxonomic status of the current
specieswithinthegenusCryptosporidiumcanbeclearly
deﬁned. Genetic data has shown that C. parvum is not
a uniform species. Eight diﬀerent genotypes within
C. parvum have been described: human, cattle, pig,
mouse, kangaroo, dog, ferret and monkey genotype
[10]. To date, with the exception of the cattle geno-
type, each of these types occur only in their respective
hosts, suggesting host speciﬁcity [10]. There are two
diﬀerent genotypes of C. parvum infecting immuno-
competent humans and cattle; a human and a bovine
genotype respectively, with the later genotype being
zoonotic [3, 11–14]. As the human genotype appears
to be host speciﬁc, this could result in a higher infec-
tivity of the human genotype compared to the cattle
genotype in humans [3, 15–17].
In Switzerland, detection of Cryptosporidium par-
vum is not routinely done in laboratories of clinical
microbiology and there is no obligation to communi-
cate isolations of this pathogen to health authorities.
For these reasons, frequency of cryptosporidiosis
and sources of infection were only poorly known.
In the past 15 years, only three epidemiological
studies in the context of cryptosporidiosis were per-
formed. Initial research work estimated the fre-
quency of Cryptosporidium spp. in faecal samples of
immunocompetent children with gastroenteritis [18].
In the case of toddlers, other authors have shown
person-to-person contacts as the most important way
of transmission [19, 20]. Finally, a most recent study
revealed data about the frequency of Cryptosporidium
spp. in Switzerland. Faeces from 6435 ambulatory
and hospitalized diarrhoeal patients were screened for
Cryptosporidium spp. over the period of one year
in two laboratories. In total, 13 patients with crypto-
sporidiosis were detected which results a frequency
of 0.2%. A crude estimate of the total number of
cryptosporidiosis cases which would have to be ex-
pected yearly in Switzerland if routine diagnostics for
this organism were done in the same frequency as for
salmonella and campylobacter and if laboratory iso-
lates were reported to the Federal Health Authorities
revealed a total value of 340 yearly cases in Switzer-
land, which results a morbidity of 4.85 per 100000
persons of the Swiss population [21]. Twelve isolates
positive for Cryptosporidium spp. from this survey
were genotyped in the present study which allowed a
more precise insight into the epidemiological charac-
teristics of cryptosporidiosis in Switzerland.
MATERIALS AND METHODS
Stool samples positive for Cryptosporidium spp.
Genotyping included Cryptosporidium spp. isolates
from 12 stool samples collected in a former study [21].
Additionally, three faecal samples positive for Crypto-
sporidium spp. from Swiss calves were kindly supplied
by the Cantonal Laboratory Basel-Landschaft and
included into the typing experiments.
Genotyping
Human and calf stool samples containing oocysts of
Cryptosporidium spp. were stored at 4 xCi n2 .5%
potassium dichromate solution until they were used.
The oocysts were puriﬁed by a sucrose and Percoll
gradient method [22]. DNA was isolated from the
puriﬁed oocysts as previously described [23]. A mod-
iﬁed two-step nested-PCR protocol, previously de-
scribed [24], was used to amplify the HSP70 gene [25].
PCR products were puriﬁed using Qiagen spin col-
umns (QIAquick Gel Extraction Kit, Germany), and
sequenced by a Swiss company (Microsynth GmbH).
Analysis of sequence data
The sequences were aligned with the ClustalW se-
quence alignment program [26] and phylogenetic
analysis of HSP70 sequence data was conducted using
the Phylogeny Inference Package PHYLIP 3.5c [27].
Distance-basedanalyseswereconductedusingthefor-
mula for Kimura’s Two-Parameter Model (for esti-
mating the number of nucleotide substitutions per site
between sequences). Phylogenetic trees were con-
structed using the Unweighted Pair-Group Method
(UPGMA) algorithms available in PHYLIP 3.5c.
Phylograms were drawn using the TreeView 1.6.1 pro-
gram [28]. Supplemental HSP70 sequences were
664 R. Fretz and othersobtained from GenBank: a bovine C. parvum iso-
late (AF221528), C. canis (AF221529), a mouse geno-
type (AF221530), a marsupial genotype (AF221531),
a human genotype (AF221535), C. meleagridis
(AF221537), C. felis (AF221538), C. baileyi
(AF221539), C. serpentis (AF221541) and C. muris
(AF221542).
RESULTS AND DISCUSSION
Genotyping experiments were successful with 9 of
total 12 (75%) Cryptosporidium spp. isolates from
human stool samples. All HSP70 sequences belonged
to the bovine genotype of C. parvum, as shown in
Figure 1. Three human isolates could not be ampliﬁed
although several attempts to genotype have been
undertaken. Surprisingly, in one sample (H12), re-
peated PCR-reactions revealed two diﬀerent geno-
types: the bovine C. parvum genotype (H12.1) and
another (H12.2). Sequence identities of sample H12.2
with the reference genotypes were as follows: with
the bovine genotype of C. parvum:9 7 .5%; with the
human genotype of C. parvum:9 5 .3% and with the
mouse genotype: 96.4%. All three isolates from
calves demonstrated clearly the bovine genotype of
C. parvum. The inability to genotype the remaining
three Cryptosporidium spp. isolates from human stool
samples was probably due to the fact that only very
small amounts of faecal materials was available.
Furthermore, the extraction technique used resulted
in low DNA yields. All sequences were submitted
to NCBI GenBank (accession numbers AY151404–
AY151416).
Humans are susceptible both to the human and to
the bovine genotype of C. parvum, and mixed infec-
tions have been shown to occur [29–31]. In Australia,
the majority of sporadic cases (85%) were caused by
the human genotype, suggesting that infection with
anthroponotic parasites played a more important role
than infection with zoonotic parasites in these indi-
viduals [3, 32, 33]. In contrast, the C. parvum bovine
genotype was responsible for more sporadic human
cases in the UK (57%) than the C. parvum human
genotype [3, 17]. Interestingly, 14 investigated out-
breaks in North America were dominated by the
human genotype of C. parvum (human genotype:
71%, cattle genotype: 29%) [3].
Genotyping in the present study exclusively re-
vealed the bovine genotype of C. parvum. Three of the
nine persons with genotyped Cryptosporidium spp.
isolates had travelled abroad prior to onset of symp-
toms and the remaining six persons were infected in
their home country. Out of those, two persons had
consumed raw milk and raw cream, foods known to
be risk factors for cryptosporidiosis [21].
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Fig. 1. Phylogram of Kimura’s distance generated from HSP70 sequence information (using UPGMA) with the Crypto-
sporidium spp. isolates from human (‘H’) and from calf stool samples (‘C’) and with diﬀerent references of Cryptosporidium
spp.
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within the ﬁrst 3 months of life is very high (16.8%)
[34], we came to the conclusion that the bovine geno-
type ofC. parvum must be themost importantcauseof
sporadic cryptosporidiosis in Switzerland with cattle
as the probable primary reservoir. This conclusion is
also supported by the above mentioned consumption
of raw milk and raw cream by two patients.
The reported predominance of the bovine genotype
is interesting in relation to the previous ﬁndings that
showed person-to-person transmission as a major risk
factor in the same area of Switzerland [19, 20]. The
ﬁndings can be reconciled as ﬁrstly, that both human
and bovine genotypes may be transmitted from per-
son-to-person [35]. Secondly, one third of the patients
where the genotyped strains originated from had
contact with symptomatic persons prior to onset of
symptoms [21].
For the prevention of cryptosporidiosis, personal
hygiene is of central importance. However, the high
prevalence of Cryptosporidium spp. in cattle and the
predominance of the bovine genotype in cases of
human cryptosporidiosis also requires particular
measures of food hygiene which are the appropriate
heating of raw milk and products thereof prior to
consumption. This measure, preventing infections
with various pathogens transmittable by raw milk, is
oﬃcially recommended by the Swiss Federal Health
Authorities [36].
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